1363 related articles for article (PubMed ID: 17030170)
21. Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors.
Simrén M; Abrahamsson H; Björnsson ES
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):201-8. PubMed ID: 17174611
[TBL] [Abstract][Full Text] [Related]
22. Episodic nature of symptoms in irritable bowel syndrome.
Palsson OS; Baggish J; Whitehead WE
Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
[TBL] [Abstract][Full Text] [Related]
23. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
Király A; Csizmadia C; Illés A; Undi S
Orv Hetil; 2006 Mar; 147(9):421-6. PubMed ID: 16619961
[TBL] [Abstract][Full Text] [Related]
24. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
Malagelada JR
Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
[TBL] [Abstract][Full Text] [Related]
25. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
26. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
27. Review article: abdominal bloating and distension in functional gastrointestinal disorders--epidemiology and exploration of possible mechanisms.
Agrawal A; Whorwell PJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):2-10. PubMed ID: 17931344
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
29. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
[TBL] [Abstract][Full Text] [Related]
31. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
Ong DK; Mitchell SB; Barrett JS; Shepherd SJ; Irving PM; Biesiekierski JR; Smith S; Gibson PR; Muir JG
J Gastroenterol Hepatol; 2010 Aug; 25(8):1366-73. PubMed ID: 20659225
[TBL] [Abstract][Full Text] [Related]
32. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
[TBL] [Abstract][Full Text] [Related]
33. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
34. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
[TBL] [Abstract][Full Text] [Related]
35. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.
Hellström PM; Saito YA; Bytzer P; Tack J; Mueller-Lissner S; Chang L
Am J Gastroenterol; 2011 Jul; 106(7):1299-307. PubMed ID: 21448146
[TBL] [Abstract][Full Text] [Related]
37. Heart rate variability is related to pain severity and predominant bowel pattern in women with irritable bowel syndrome.
Cain KC; Jarrett ME; Burr RL; Hertig VL; Heitkemper MM
Neurogastroenterol Motil; 2007 Feb; 19(2):110-8. PubMed ID: 17244165
[TBL] [Abstract][Full Text] [Related]
38. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
[TBL] [Abstract][Full Text] [Related]
39. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
[TBL] [Abstract][Full Text] [Related]
40. Irritable bowel syndrome and bloating.
Hasler WL
Best Pract Res Clin Gastroenterol; 2007; 21(4):689-707. PubMed ID: 17643909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
